Wave Life Sciences Ltd. Reports Board Changes and Filings
Ticker: WVE · Form: 8-K · Filed: Aug 12, 2024 · CIK: 1631574
| Field | Detail |
|---|---|
| Company | Wave Life Sciences Ltd. (WVE) |
| Form Type | 8-K |
| Filed Date | Aug 12, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, filing, officer-compensation
TL;DR
Wave Life Sciences filed an 8-K detailing board changes, officer comp, and submitted matters for a shareholder vote.
AI Summary
Wave Life Sciences Ltd. announced on August 6, 2024, a change in its board of directors, with the election of Dr. Paul Bolno and Mr. David Epstein. The company also reported on compensatory arrangements for its officers and submitted matters to a vote of security holders. Financial statements and exhibits were also filed as part of this report.
Why It Matters
Changes in board composition and officer compensation can signal strategic shifts or governance updates within the company, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board changes and officer compensation disclosures can sometimes precede or accompany significant corporate events, requiring investors to monitor for further developments.
Key Players & Entities
- Wave Life Sciences Ltd. (company) — Registrant
- Dr. Paul Bolno (person) — Elected Director
- Mr. David Epstein (person) — Elected Director
- August 6, 2024 (date) — Earliest event reported
FAQ
Who were the new directors elected to the Wave Life Sciences Ltd. board?
Dr. Paul Bolno and Mr. David Epstein were elected to the board of directors.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated August 6, 2024.
What types of information are included in this 8-K filing besides director changes?
The filing also includes information on compensatory arrangements of certain officers and submission of matters to a vote of security holders, along with financial statements and exhibits.
What is the SEC file number for Wave Life Sciences Ltd.?
The SEC file number for Wave Life Sciences Ltd. is 001-37627.
What is the SIC code for Wave Life Sciences Ltd.?
The Standard Industrial Classification (SIC) code for Wave Life Sciences Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 1,051 words · 4 min read · ~4 pages · Grade level 11.6 · Accepted 2024-08-12 17:29:01
Key Financial Figures
- $0 — of each exchange on which registered $0 Par Value Ordinary Shares WVE The N
Filing Documents
- d746777d8k.htm (8-K) — 57KB
- d746777dex101.htm (EX-10.1) — 91KB
- 0001193125-24-199020.txt ( ) — 295KB
- wve-20240806.xsd (EX-101.SCH) — 3KB
- wve-20240806_lab.xml (EX-101.LAB) — 18KB
- wve-20240806_pre.xml (EX-101.PRE) — 11KB
- d746777d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1+ Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as amended 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) + Indicates management contract or compensatory plan or arrangement.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WAVE LIFE SCIENCES LTD. By: /s/ Paul B. Bolno, M.D. Paul B. Bolno, M.D. President and Chief Executive Officer Date: August 12, 2024